By Willow Tohi, Natural News
- U.S. Senate hearing scheduled for June 2 will investigate biological mechanisms by which COVID-19 vaccines may increase cancer risks
- A systematic review of 69 studies published in Oncotarget identified possible safety signals linking vaccines to leukemia, lymphoma, breast and lung cancer
- A South Korean study of 8.4 million people found a 27% higher overall cancer risk and statistically significant links to six cancer types among vaccinated individuals
- British oncologist Dr. Angus Dalgleish has told Parliament he witnessed long-stable cancer patients suffer aggressive relapses after third or subsequent booster doses
- Multiple scientists scheduled to testify have faced censorship, including retracted papers and social media restrictions
(Natural News)—A U.S. Senate hearing scheduled for Wednesday afternoon will feature testimony from oncologists and researchers who say scientific evidence suggests COVID-19 vaccination may be linked to increased cancer risks. The hearing, titled “Plausible Mechanisms of COVID-19 Injections Causing Cancer and Attacks on Scientific Publications,” comes as multiple large-scale studies and clinical observations have raised concerns that warrant further investigation. Sen. Ron Johnson, chair of the Permanent Subcommittee on Investigations, will lead the hearing at 2:30 p.m. EST as doctors and scientists present findings that they say have been suppressed by medical journals and social media platforms.
The evidence mounts: Cancer signals in large populations
The hearing will feature a systematic review of 69 studies and reports published in the journal Oncotarget by Dr. Wafik El-Deiry, director of the Legorreta Cancer Center at Brown University, and Dr. Charlotte Kuperwasser of Tufts University. Their review identified mechanisms — including spike protein effects and DNA contamination found in some COVID-19 vaccine types — that might trigger cancer development.